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Abstract
Background: Following World Health Assembly resolutions 50.36 in 1997 and 56.7 in 2003, the World Health
Organization (WHO) committed itself to supporting human African trypanosomiasis (HAT)-endemic countries in
their efforts to remove the disease as a public health problem. Mapping the distribution of HAT in time and space
has a pivotal role to play if this objective is to be met. For this reason WHO launched the HAT Atlas initiative,
jointly implemented with the Food and Agriculture Organization of the United Nations, in the framework of the
Programme Against African Trypanosomosis.
Results: The distribution of HAT is presented for 23 out of 25 sub-Saharan countries having reported on the status
of sleeping sickness in the period 2000 - 2009. For the two remaining countries, i.e. Angola and the Democratic
Republic of the Congo, data processing is ongoing. Reports by National Sleeping Sickness Control Programmes
(NSSCPs), Non-Governmental Organizations (NGOs) and Research Institutes were collated and the relevant
epidemiological data were entered in a database, thus incorporating (i) the results of active screening of over 2.2
million people, and (ii) cases detected in health care facilities engaged in passive surveillance. A total of over 42
000 cases of HAT and 6 000 different localities were included in the database. Various sources of geographic
coordinates were used to locate the villages of epidemiological interest. The resulting average mapping accuracy is
estimated at 900 m.
Conclusions: Full involvement of NSSCPs, NGOs and Research Institutes in building the Atlas of HAT contributes to
the efficiency of the mapping process and it assures both the quality of the collated information and the accuracy
of the outputs. Although efforts are still needed to reduce the number of undetected and unreported cases, the
comprehensive, village-level mapping of HAT control activities over a ten-year period ensures a detailed and
reliable representation of the known geographic distribution of the disease. Not only does the Atlas serve research
and advocacy, but, more importantly, it provides crucial evidence and a valuable tool for making informed
decisions to plan and monitor the control of sleeping sickness.
Background
Efficient collection, management and dissemination of
information are essential to intervene effectively against
neglected tropical diseases and to monitor and evaluate
strategies and actions towards their control. However,
the neglect suffered by many diseases that affect the
world’s poorest people manifests itself in many guises,
not least in the paucity of reliable information on their
incidence and geographic distribution [1,2]. Evidence on
the number and location of infections is badly needed
to bring these neglected diseases out of the shadow [3]
and, most crucially, to tackle them efficiently [4,5].
Disease maps are required for planning, managing and
monitoring interventions across the whole spectrum of
neglected tropical diseases. For conditions such as
helminthiases and trachoma, against which safe and
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are used to plan mass drug administration (MDA)
campaigns [6-8]. As campaigns progress, spatially-explicit
data enable implementation to be monitored and ulti-
mately contribute to assessing the degree of success of the
initiatives [9]. Geo-spatial information also plays a role in
the post-MDA phase when surveillance aims at providing
early-warning of the possible disease resurgence or rein-
troduction in freed areas.
A different group of diseases such as human African
trypanosomiasis (HAT), Chagas disease and leishmania-
sis, are characterized by the limited availability of safe
and cost-effective control tools. This group includes
infections of complex epidemiology, which, if untreated,
can result in very high death rates. Strategies to control
them hinge on early diagnosis and treatment, as well as
on vector control. Accurate, spatially-explicit informa-
tion is essential to target, monitor and evaluate interven-
tions against these challenging and deadly diseases
[10-12].
Geo-referenced data are also crucial when control
strategies are successful and elimination or eradication
of a disease can be contemplated. This is exemplified by
the “Dracunculiasis Eradication Program”, wherein vil-
lage-level information on disease occurrence and pro-
gramme implementation is routinely collected to
monitor progress towards the programme’s ultimate
goal [13].
Disease distribution maps are also required if accurate
estimates of the population at risk and of the burden of
diseases are to be made. The issue of the most appropriate
metrics to estimate the burden is subject of debate [14,15],
but there is increasing recognition that the burden of
neglected tropical diseases still needs to be fully appre-
ciated [16] and that more detailed and reliable data on
their incidence and impacts need to be collected [17-19].
The present paper focuses on HAT, also known as
sleeping sickness, whose etiological agents are tsetse-
transmitted protozoa of the species Trypanosoma brucei.
Two sub-species are responsible for syndromes of mark-
edly different epidemiology and geographical range.
T. b. gambiense causes the chronic, anthroponotic form
found in Western and Central Africa. Infection with
T. b. rhodesiense results in the acute, zoonotic form of
Eastern and Southern Africa. Both forms are considered
fatal if untreated. No vaccine against HAT is available,
and the toxicity of existing drugs precludes the adoption
of control strategies based on preventive chemotherapy.
As a result, the keystones of interventions against sleep-
ing sickness are active and passive case-finding followed
by treatment, vector control and animal reservoir
management.
Following World Health Assembly resolutions 50.36 in
1997 [20] and 56.7 in 2003 [21], the World Health
Organization (WHO) committed itself to supporting
HAT-endemic countries in their efforts to remove the
disease as a public health problem. Mapping disease dis-
tribution in time and space has a pivotal role to play if
this objective is to be met.
Partly because of the focal nature of sleeping sickness
geography, HAT control has always been intimately
entwined with disease mapping [22]. For example, as
early as 1903, detailed maps of HAT distribution were
p u b l i s h e di nU g a n d a[ 2 3 ]a n df o c iw e r em a p p e di n
Western and Central Africa in the period 1908-1910
[24,25]. In the last decade, mapping and geo-positioning
have become much more accessible with the widespread
diffusion of Geographic Information Systems (GIS) and
satellite-aided positioning systems (e.g. the Global Posi-
tioning System (GPS)). These technical tools are at the
basis of the systematic approach to sleeping sickness
mapping embodied in the Atlas of HAT, the first
attempt ever to geo-reference at the village level all
sleeping sickness cases reported from affected countries
[26]. Underpinning this initiative are the commitment of
WHO and the Food and Agriculture Organization of
the United Nations (FAO), the institutional umbrella
provided by the Programme against African Trypanoso-
mosis (PAAT) and the crucial input of National
Sleeping Sickness Control Programmes (NSSCPs), Non-
Governmental Organizations (NGOs) and Research
Institutes.
This paper presents the process of building the Atlas
of HAT for the period 2000-2009. The distribution of
HAT is presented for 23 out of 25 sub-Saharan coun-
tries having reported on the status of sleeping sickness
during the last ten years: Benin, Burkina Faso, Camer-
oon, Central African Republic, Chad, Congo, Côte
d’Ivoire, Equatorial Guinea, Gabon, Ghana, Guinea,
Kenya, Malawi, Mali, Mozambique, Nigeria, Rwanda,
Sudan, Togo, Uganda, United Republic of Tanzania,
Zambia and Zimbabwe. Work is in progress to process
data from the two remaining countries having reported
on HAT in the study period: Angola and the Demo-
cratic Republic of the Congo (DRC).
The presented maps are a fundamental milestone in
the process of building the continental Atlas of HAT.
The unprecedented accuracy and comprehensiveness of
t h eA t l a sa r et om a k ei ta ne s s e n t i a lt o o lf o rd i s e a s e
control, research and advocacy.
Methods
The central feature of the Atlas of HAT is the mapping
at village level of all new cases of HAT reported during
a ten-year period (2000-2009, see Table 1 for T. b. gam-
biense and Table 2 for T. b. rhodesiense).
In addition to the new HAT reported cases, results of
all active case-finding surveys are also included in the
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important information on the populations screened and
the epidemiological status of historical transmission
areas.
Data from both active and passive surveillance are
analyzed and imported into a single database, where a
selected set of ancillary data are also recorded if
available (i.e. number of people screened, number of
people living in screened localities, disease stage).
Since the methodology used to build the HAT data-
base has been described in detail elsewhere [26], this
section elaborates only on those key methodological
aspects that have repercussions on mapping accuracy
and on the epidemiological interpretation of the outputs.
Table 1 T. b. gambiense Sleeping Sickness: new cases reported between 2000 and 2009
Country 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Total
Angola 4,546 4,577 3,621 3,115 2,280 1,727 1,105 648 517 247 22,383
Benin
1 000000000 0 0
Burkina Faso
2 000000000 0 0
Cameroon
3 27 14 32 33 17 3 15 7 13 24 185
Central African Republic
4 988 718 572 539 738 666 460 654 1,194 1,054 7,583
Chad 153 138 715 222 483 190 276 97 196 510 2,980
Congo
5 111 894 1,005 717 873 398 300 189 182 87 4,756
Côte d’Ivoire
6 188 92 97 68 74 42 29 13 14 8 625
Democratic Republic of the Congo 16,975 17,322 13,853 11,481 10,369 10,269 8,023 8,162 7,326 7,183 110,963
Equatorial Guinea 16 17 32 23 22 17 13 15 11 7 173
Gabon
7 45 30 26 26 49 53 31 30 24 14 328
Gambia - - - - - - - - - - 0
Ghana 1 0 0000000 0 1
Guinea
8 52 72 132 130 95 94 48 69 90 79 861
Guinea-Bissau - - - - - - - - - - 0
Liberia - - - - - - - - - - 0
Mali
9 000000000 0 0
Niger - - - - - - - - - - 0
Nigeria 14 14 26 31 10 21 3 0 0 0 119
Senegal - - - - - - - - - - 0
Sierra Leone - - - - - - - - - - 0
Sudan
10 1,801 1,919 3,121 3,061 1,742 1,853 789 469 623 376 15,754
Togo 0 0 0000000 0 0
Uganda
11 948 310 604 517 378 311 290 120 198 99 3,775
Total reported 25,865 26,117 23,836 19,963 17,130 15,644 11,382 10,473 10,388 9,688 170,486
“-”, no data reported.
“0”, no cases reported despite active and passive surveillance is in place.
For countries in italics (Angola and Democratic Republic of the Congo) data processing is still in progress.
1Data for Benin include revisions of previously published figures [27,28], Suspected cases reported between 2000 and 2003 were not confirmed by verification
and follow-up missions [29].
2Data for Burkina Faso include revisions of previously published figures [27,28]. Cases reported from Burkina Faso between 2000 and 2004 have been labelled as
“transboundary” and subsequently attributed to Côte d’Ivoire, the country of infection [29].
3Previously published number of cases from Cameroon in 2001 [27,28] has been revised to include one case “exported” to Germany.
4Data for Central African Republic include revisions of previously published figures for the years from 2001 to 2003 [27,28]. Revisions arose from a re-assessment
of the epidemiological data, including ward and laboratory books, reports of active case-finding surveys and “exported” cases.
5Data for Congo include revisions of previously published figures for the years 2003 and 2004 [27,28]. Revised figures include cases diagnosed by NGOs.
6Data for Côte d’Ivoire include revisions of previously published figures for the years 2000 to 2005 [27,28]. Revisions arose from a re-assessment of the
epidemiological data, including ward and laboratory books, reports of active case-finding surveys and “transboundary” cases diagnosed in Burkina Faso.
7Previously published number of cases from Gabon in 2002 and 2004 [27,28] have been revised to include cases “exported” to France and Italy.
8Data for Guinea include revisions of previously published figures for the years from 2002 to 2004 [27,28]. Revisions arose from a re-assessment of the
epidemiological data, including ward and laboratory books, reports of active case-finding surveys and “exported” cases.
9Data for Mali include revisions of previously published figures [27,28]. Suspected cases reported between 2000 and 2002 were not confirmed by verification and
follow-up missions [29].
10Data for Sudan include revisions of previously published figures for the years 2000 to 2006 [27,28]. Revisions arose from the re-assessment of transboundary
cases and the inclusion of exported cases.
11Data for Uganda include revisions of previously published figures for the years 2000 to 2006 [27,28]. Revisions arose from the re-assessment of transboundary
cases and the inclusion of exported cases.
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Data on HAT cases detected by active case-finding sur-
veys are collected by mobile teams visiting villages in
transmission areas. As a rule, people are tested in their
village of residence, which therefore is used as the refer-
ence for mapping. However, participants in a mass-
screening event carried out in a given village may also
comprise people coming from neighbouring settlements,
normally located only a few kilometres away. If these
settlements of origin are explicitly mentioned in the
mission report, it is possible to refer the relevant indivi-
duals back to their exact place of residence, thus more
accurately reflecting in the Atlas the epidemiological
milieu in which they live. If information on the exact
place of residence is not available, cases are mapped in
the village where the screening took place.
For HAT cases detected by passive surveillance in
referral healthcare facilities, the patient’s village of resi-
dence is normally recorded in laboratory and ward reg-
ister books and thus it can be used for mapping.
Therefore, the patient’s village of residence constitutes
the basic mapping unit for both actively and passively
reported cases.
Hospital records pointing to villages of residence
located far from known endemic areas are investigated
on a case-by-case basis, with a view towards ascertaining
the accuracy of the recorded information and clarifying
its epidemiological significance. Indeed, cultural factors
and communication difficulties may lead the patient to
declare, or the doctor or technician to record, the
patient’s place of birth or the place of origin of their
family as their village of residence. The mapping process
often allows these issues to be identified.
More generally, careful verification is carried out for all
outliers (e.g. places of residence that are inconsistent with
the catchment area of the reporting healthcare structure,
cases falling outside tsetse-infested areas, etc). Cases origi-
nating from areas with no reported history of HAT
undergo special scrutiny, as they could point to new trans-
mission zones requiring in-depth field investigation.
Other challenges to HAT mapping are posed by refu-
gees and internally displaced people who are mapped in
their camps if their village of residence is unknown; sol-
diers are mapped in the localities where they are sta-
tioned. Mapping of other categories of migrating
workers, for whom establishing the most meaningful
place of residence is a demanding endeavour, is guided
by knowledge of the local epidemiology of the disease
and perspectives given by the long field-experience of
NSSCPs staff.
Table 2 T. b. rhodesiense Sleeping Sickness: new cases reported between 2000 and 2009
Country 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Total
Botswana -----------
Burundi -----------
Ethiopia -----------
Kenya
1 1 5 1 0 1 10001001 3 8
Malawi
2 35 38 43 70 48 41 58 50 49 39 471
Mozambique - - 1 - 1 - - - - - 2
Namibia -----------
Rwanda
3 00000000000
Swaziland -----------
Uganda
4 300 426 329 338 335 473 261 119 138 129 2,848
United Republic of Tanzania
5 350 277 228 113 159 186 127 126 59 14 1,639
Zambia
6 9 4 5 15 9 7 6 10 13 4 82
Zimbabwe
7 00000300036
Total 709 755 617 536 552 710 453 305 259 190 5,086
“-”, no data reported.
“0”, no cases reported despite passive surveillance is in place.
1Data for Kenya include revisions of previously published figures for the years 2000 to 2002 [27,28]. Revised figures include “transboundary” cases diagnosed in
Uganda.
2The previously published figure for Malawi in 2004 [27,28] has been revised. The revised figure includes a case “exported” from Malawi to United Kingdom.
3Data for Rwanda include revisions of previously published figures for the years 2001 and 2004 [27,28], which had been affected by an error in the yearly reports
to WHO (Data verified through a joint assessment by the Rwandan Ministry of Health and WHO).
4Data for the Uganda include revisions of previously published figures for the year 2000 and the years from 2002 to 2006 [27,28]. Revisions arose from a re-
assessment of the epidemiological data, including ward and laboratory books. “Transboundary” cases from Kenya have also been considered.
5Data for the United Republic of Tanzania include revisions of previously published figures for the years from 2000 to 2006 [27,28]. The revised includes all cases
“exported” from the United Republic of Tanzania to other countries.
6Data for Zambia include revisions of previously published figures for the years 2001 and 2006 [27,28], which had been affected by an error in the yearly reports
to WHO (Data verified through a joint assessment by the Zambian Ministry of Health and WHO). “Exported” cases have also been included.
7The previously published figure for Zimbabwe in 2005 [27,28] has been revised following a re-assessment of epidemiological reports.
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provide details on all cases that required ad-hoc inves-
tigation, so as to make the interpretation process
transparent to users.
HAT cases are also occasionally diagnosed in a
country that is different from the country where the
patient contracted the infection. This is relatively fre-
quent between HAT-endemic countries as a result of
transboundary foci. To capture these cases the Atlas
presents the special category “transboundary case”.
The corresponding individuals are mapped in the vil-
lage of residence in the country of infection and
flagged accordingly as “transboundary cases”.T h e
place and country of diagnosis are also recorded in the
notes of the database with a view to understanding
population movements within transboundary foci.
HAT infections are also diagnosed in countries that
are not endemic for HAT, including countries outside
Africa, mostly in migrants and tourists who come from
or have visited endemic areas. The category of
“exported case” has been created in the HAT Atlas to
reflect this phenomenon. In the maps presented in this
paper, exported cases are associated to the probable
place of infection; in the case of tourists, this is most
often represented by the centroid of a national park or
another wildlife management area. The importing
countries, as well as the places of diagnoses, are also
recorded in the notes of the database, which will
allow a “World map” of HAT exported cases to be
generated.
How to georeference HAT cases
Once the village to be mapped has been determined, its
geographic coordinates must be measured or estimated.
A procedure was devised whereby coordinates are first
sought in the epidemiological reports [26]. When not
available there, coordinates are searched for in gazet-
teers (i.e. databases of named locations). These two
sources enable the majority of villages to be mapped. As
a third option, other sources of geographic information
can be used, including paper and digital maps, as well as
hand-drawn, out-of-scale sketches of the endemic areas
that may be available in the epidemiological reports.
When all the available data sources have been
exhausted, a limited but non-negligible number of set-
tlements, especially the smaller or temporary, often
remain unmapped, thus calling for further investigation.
Direct consultation with first-line field workers of the
NSSCPs (either via face-to-face interviews, cell-phone or
e-mail) has proved the most speedy and cost-effective
manner to locate - most frequently in relation to other
known locations - hundreds of these small and often
remote settlements.
Mapping accuracy
The various sources of geographic information used to
build the HAT Atlas are characterized by different levels
of accuracy. To estimate the overall spatial accuracy of
the resulting maps we classified mapped locations into
four broad categories of accuracy: very high, high, mod-
erate and low.
The first category, i.e. “very high accuracy”,i n c l u d e s
locations whose coordinates were derived from GPS
measurements carried out by field teams in charge of
HAT reporting. These measurements can be affected by
an error as little as a few metres, but we conservatively
estimated an average error of 50 m. Certain coordinates
obtained from gazetteers are also included in the first
category of accuracy, but only if no rounding of the
coordinates was carried out (i.e. coordinates must be
available from gazetteers in full, as degrees, minutes and
seconds, or down to the 4
th decimal place if decimal
degrees notation was used).
The second category (“high accuracy”) includes all those
cases where coordinates obtained from gazetteers have, for
some reason, been rounded (or truncated) at the source.
For example, in the GEOnet Names Server database,
which provides the baseline for many, if not all, of the
available gazetteers [30], more than half of the coordinates
for Africa are rounded to the nearest minute, which results
in errors of up to 928 m. For this second category we
therefore estimated an average error of 500 m.
“Medium” and “low” accuracy refer to coordinates that
were estimated in an approximate manner, i.e. by using
digital and paper maps, out-of-scale sketches of survey
areas, as well as qualitative information received from
field-workers. The difference between the two categories
lies in the detail of the qualitative information they are
based upon. For example, “medium” accuracy may derive
from indications such as “the village to be mapped is
located at 1 kilometre from village ×, along the road to
village y”, with the obvious assumption that the position
of villages × and y and the road connecting them be
known. By contrast, “low” accuracy may result from less
precise indications, such as “village × is located between
village y and village z, along the river w”.W ee s t i m a t ea n
average accuracy of 2,500 m and 5,000 m for the cate-
gories “medium” and “low” respectively.
Definition of HAT case
The Atlas aims to map all new HAT cases reported by
affected countries. As a rule, NSSCPs consider parasitolo-
gical confirmation (i.e. direct observation of trypanosomes
in bodily fluids) as mandatory for HAT diagnosis. How-
ever, under certain circumstances, NSSCPs consider a ser-
opositive individual as affected, even in the absence of
parasitological confirmation. This occurs more frequently
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where the likelihood of false positives in serological tests is
deemed lower. For the Atlas of HAT we simply follow
national rules for the definition of HAT cases. However, in
the database note is taken of all the instances when
NSSCPs have included seropositives without parasitologi-
cal confirmation in the totality of HAT cases.
Results
Mapping of HAT
As we write, mapping in 23 countries out of the 25 that
reported on HAT occurrence in the period 2000-2009
has been completed (Figure 1). Data processing is con-
sidered complete when all available data sources for the
study period have been analysed and entered in the
database. Approximately 1 500 unpublished files, includ-
ing epidemiological reports, maps, databases and spread-
sheets, have been analyzed for the 23 study countries,
thus incorporating (i) the results of active screening of
over 2.2 million people, and (ii) cases detected in health
care facilities engaged in passive surveillance. A total of
over 42 000 cases of HAT and 6 000 different localities
have been included in the database. Work is in progress
to process data from the 2 remaining countries having
reported the largest burden of HAT cases in the study
period: Angola and DRC (represented with a striped
pattern in Figure 1). Eight countries listed as endemic
have provided no report on the HAT situation in 2000-
2009: Burundi, Ethiopia, Gambia, Guinea-Bissau, Liberia,
Niger, Senegal and Sierra Leone (represented with a yel-
low chequerboard pattern in Figure 1). Efforts should be
made to clarify the epidemiological status of HAT
in these eight countries. In Botswana, Namibia and Swa-
ziland (represented with a green chequerboard pattern
in Figure 1), it is suggested that transmission of sleeping
sickness may have been interrupted because of
Figure 1 The Atlas of human African trypanosomiasis: progress status. For each country, data processing is considered complete when all
available data sources for the study period (2000-2009) have been analysed and included in the HAT database.
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mented in Botswana and Namibia [31-33], as well as
evidence indicating that Glossina austeni - a species not
involved in HAT transmission [34,35] - is currently the
only species of tsetse fly present in Swaziland [36].
To date, not all cases reported from completed coun-
tries could be mapped. Table 3 shows that approxi-
mately 10 percent of cases could not be geo-referenced
at the village level yet, although the focus of origin is
known. The majority of gaps in mapped cases originate
from passive surveillance, as the number of sleeping
sickness cases may be reported as focus-level aggregates,
without specific reference to the patients’ village of resi-
dence. Despite actions to visit the source for more
detailed data, it occurs that the necessary village-level
information may have been permanently lost, especially
because of the violent conflicts that ravaged numerous
HAT endemic areas in recent years.
HAT distribution
Present results of the HAT Atlas initiative are shown in
Figure 2, Figure 3 and Figure 4, which represent the dis-
tribution of both forms of HAT in 23 countries.
Western Africa
In Western Africa (Figure 2), three countries are still
reporting significant levels of disease incidence: Guinea,
Côte d’Ivoire and Nigeria. In Guinea, HAT cases origi-
n a t ef r o mt h em a n g r o v eb i o t o p e( Guinée Maritime)
where people expose themselves to the risk of infection
when fishing, growing rice and collecting firewood and
salt. This region includes the foci of Boffa, Dubréka and
Forécariah, the latter close to the border with Sierra
L e o n e .T h ep r e s e n c eo ft h es a m em a n g r o v eb i o t o p e
across this porous border suggests that the disease
might also be present in the territory of Sierra Leone,
even though no case is reported from this country.
However, an exploratory mission carried out in early
2010 in 24 villages of Sierra Leone close to the Guinean
border (results included in Figure 2) failed to find evi-
dence of HAT [37]. In Guinea, HAT cases are also
reported from the forest biotope (Guinée Forestière),
namely from N’zérékoré and Guéckédou foci.
In Côte d’Ivoire, transmission is reported among
workers of cocoa and coffee plantations in the Centre-
west of the country that comprises the foci of Daloa
(Haut-Sassandra Region), Sinfra and Bonon (Marahoué
Table 3 Progress status of mapping for HAT cases and geographic locations (period 2000 - 2009)
Country HAT cases Geographic locations
1
Reported (number) Mapped (%) Reported (number) Mapped (%)
Benin 0 - 194 100.0
Burkina Faso 0 - 32 100.0
Cameroon 185 100.0 111 100.0
Central African Republic 7,583 97.1 420 94.5
Chad 2,980 82.7 230 89.6
Congo 4,756 96.1 889 98.3
Côte d’Ivoire 625 91.0 237 96.6
Equatorial Guinea 173 100.0 111 100.0
Gabon 328 100.0 237 100.0
Ghana 1 100.0 99 97.0
Guinea 861 95.7 290 91.7
Kenya 38 100.0 27 100.0
Malawi 471 82.0 125 84.8
Mali 0 - 244 84.8
Mozambique 2 100.0 2 100.0
Nigeria 119 100.0 23 100.0
Rwanda 0 - 0 -
Sudan 15,754 82.4 692 88.3
Togo 0 - 90 100.0
Uganda 6,623 98,1 1,902 85,2
United Republic of Tanzania 1,639 93.5 45 88.9
Zambia 82 100.0 29 100.0
Zimbabwe 6 100.0 5 100.0
TOTAL 42,226 90.3 6,035 91,4
1Geographic locations also include those where active screening was carried out but no case was detected.
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are also reported from the South-eastern (Aboisso, Sud
Comoe Region) and Western (Moyen Cavally Region)
parts of the country.
Nigeria reports cases from Edo and Delta States,
where security constraints prevent more accurate sur-
veys that could delineate the exact extent of the focus.
By contrast, extensive active screening surveys in Benin,
Burkina Faso, Ghana, Mali and Togo have not revealed
any evidence of transmission in vast areas of the Suda-
nian savannah ecoregion, which includes a number of
sleeping sickness foci that had been active in the first
part of the 20
th century [29]. This evolution appears to
have been driven by demographic, climatic and land-
scape dynamics that would have shrunk the distribution
of the tsetse fly in the region and reduced the possibility
of contact between people and the vector of HAT [38].
The few cases detected in Burkina Faso in the last
decade are due to returnees who had been working in
HAT-endemic areas in Côte d’Ivoire [29].
Central Africa
The most active HAT foci of the Central African coun-
tries presented in this paper - which does not include
Angola and DRC - are found in Sudan, Central African
Republic, Congo and Uganda (Figure 3), most notably in
riverine, forested biotopes where at-risk activities
include attending to domestic chores, farming, fishing
and hunting. A notable feature of HAT distribution in
this region is the relevance of trans-boundary foci, asso-
ciated to important population movements. These
movements are often caused by insecurity, but also by
the fact that borders frequently cut across areas inhab-
ited by the same ethnic group.
In North-western Uganda most cases of Gambiense
sleeping sickness are reported, listing from East to West,
from the districts of Amuru, Adjumani, Moyo, Yumbe,
Figure 2 Cases of human African trypanosomiasis reported from Western Africa (period 2000-2009). Countries masked in white are (i)
non-endemic for HAT, or (ii) those that did not report on the HAT epidemiological situation in the period 2000-2009. Areas masked in grey
correspond to disputed territories and non-self-governing territories [39].
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Page 8 of 18Arua, Maracha-Terego and Koboko, the latter providing
most of the cases reported in recent years. In Southern
Sudan, the main foci are, from East to West: Nimule
and Kajo-Keji (linked to the Ugandan foci of Adjumani
and Moyo), Yei, Mundri, Maridi, Yambio-Ezo (linked to
the foci of the Oriental Province in DRC) and Tambura-
Source Yubu, related to the foci of Obo, Mboki and
Zemio in the South East of Central African Republic
(Haut-Mbomou Prefecture). The latter cluster of foci
also extends southwards merging with the foci of Haut
Uele in the Oriental Province of DRC. Central African
Republic also includes the foci of Batangafo and Maiti-
koulou in the North West (Ouham Prefecture). Lower
incidence is reported from the foci of Nola-Bilolo and
Lobaye in the South, which is linked with the foci in
Équateur Province of DRC. In Chad, HAT cases are
reported only from the southern foci of Bodo and Mois-
sala, associated to Mandoul and Nana Barya rivers and
linked with the Central African foci of Batangafo and
Maitikoulou. In Congo, HAT cases are concentrated in
the Bouenza Region (foci of Loudima, Boko-Songho,
Nkayi, Nkayes, Madingou, Mfouati and Yamba) and
along the Congo River and its main tributaries (e.g. the
Likouala and Sangha rivers), where the main foci are
Loukolela and Mossaka (Cuvette Region), Gamboma,
Mpouya and Makotimpoko (Plateaux Region) and
Mindouli, Ignié and Ngabé (Pool Region). The transmis-
sion areas along the Congo River are also linked to the
foci of Équateur, Bandundu, Kinshasa and Bas Congo
Provinces in the DRC. Other less active foci in the forest
biotope can be found in Cameroon (i.e. Mamfé and
Fontem in the Sud-Ouest Province, Bipindi in the Lit-
toral Province and Doumé in the Est Province).
The second important biotope of HAT transmission
in Central Africa is the mangrove swamp along the
Atlantic coast, where people are at risk of infection
when engaged in fishing or hunting activities. In Camer-
oon we find the focus of Campo, also shared with Equa-
torial Guinea, which is followed southwards by the foci
of Mbini and Kogo. The latter is linked to the focus of
Figure 3 Cases of human African trypanosomiasis reported from Central Africa (period 2000-2009). Countries masked in white are (i)
those where mapping is in progress, (ii) those that did not report on the HAT epidemiological situation in the period 2000-2009.
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Page 9 of 18Figure 4 Cases of human African trypanosomiasis reported from Eastern and South-eastern Africa (period 2000-2009).C o u n t r i e s
masked in white are (i) those were mapping is in progress, (ii) non-endemic for HAT, and (iii) those that did not report on the HAT
epidemiological situation in the period 2000-2009.
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Page 10 of 18Noya in Gabon (Estuaire Province), and lastly the focus
of Bendje (Ogooué-Maritime Province).
Eastern and South-eastern Africa
In Eastern and South-eastern Africa, affected by Rhode-
siense HAT, at-risk activities are those that bring people
into areas where livestock or wildlife interact with the
tsetse vector. Among these activities are grazing live-
stock, collection of firewood and honey, hunting, fishing
and poaching. Evidently, in addition to park rangers,
tourists are among the categories at-risk, and a number
of infections are diagnosed outside transmission areas in
tourists that had visited protected areas. Infected tour-
ists are considered as “exported cases” and mapped with
purple triangles in points that are representative of the
areas where they contracted the infection (most often
the centroids of the visited parks).
Most reported cases of Rhodesiense sleeping sickness
are linked to the livestock reservoir. Domestic cattle can
be highly mobile, and their movements along trade routes
and through livestock markets pose a serious challenge to
Rhodesiense HAT control. In some countries these move-
ments have been directly linked to the emergence of new
foci of HAT transmission [40]. In particular, it has been
shown that animals for sale at markets tend to have a
higher prevalence of infection than animals in the general
population; control of this spread therefore depends on
close collaboration with veterinary services [41].
The livestock reservoir is especially important for
South-eastern Uganda, which accounts for over 50 per-
cent of T. b. rhodesiense cases reported from Africa in
the period 2000-2009. Cases are mainly reported from
the districts of Iganga, Soroti and Kaberamaido. The lat-
ter, together with the Dokolo and Lira Districts, only
started to report a sizable number of cases in 2004 after
the northwards movements of cattle and the movements
of populations due to civil unrest. This northwards shift
represents a real risk of merger with the Gambiense
form that affects the North West of the country, which
would pose significant problems for disease control [42].
Sporadic cases of T. b. rhodesiense have also been
reported from the South-western part of Uganda in tra-
vellers visiting the Queen Elizabeth Park.
Domestic animals also play an important epidemiolo-
gical role in other countries, including Tanzania, which
reports over 30 percent of the total number of T. b. rho-
desiense cases, and Kenya. In the latter country, HAT
cases are reported from the Western Province (districts
of Bungoma, Teso and Busia), with a few Kenyan cases
being detected by health facilities across the Ugandan
border. Sporadic cases are also reported from the
Nyanza Province (Migori district).
Wildlife, especially game animals, is the other central
actor in the epidemiology of Rhodesiense sleeping
sickness.
Figure 4 shows the close spatial relationship between
HAT infections and protected areas in those countries
where the livestock (cattle) reservoir does not dominate.
I nal a r g e r - s c a l ee x a m p l e( F i g u r e5 )t h ed i s t r i b u t i o no f
sleeping sickness cases around the Nkhotakota Wildlife
Reserve in Malawi is shown. We note that a few circles
identifying HAT cases are also found within the park’s
boundary, as they refer to park’sw o r k e r s( e . g .r a n g e r s ) ,
normally residing inside the park.
Zambia has been reporting cases linked to National
Parks in the eastern and northern part of the country
(i.e. National Parks of North and South Luangwa, Isan-
gano, Kasanka and Lavushi Manda). HAT cases linked
to Kafue National Park in the South-west of the country
have also been reported. Cases detected in northern
Zimbabwe are related to Mana Pools National Park and
Kariba Lake. In Malawi, cases are clustered around
Vwaza Marsh Wildlife Reserve (Northern Region),
Nkhotakota Wildlife Reserve and Kasungu National
Park (Central Region). Mozambique is reporting spora-
dic cases in Tete and Niassa Provinces. Tanzania reports
cases of infection from the Serengeti and Tarangire
National Parks and Ngorongoro Conservation Area in
the northern part of the country. In the West, cases are
reported from health facilities in the Kigoma Region
related to the Moyowosi Game Reserve. Cases are also
reported from Tabora Region linked to the Ugalla River
Game Reserve and Rukwa Region linked to Luafi Game
Reserve and Katavi National Park.
Interestingly, only the waters of Lake Tanganyika seem
to separate the cases of T. b. gambiense in DRC from
those of T. b. rhodesiense in Tanzania, thus posing a
risk of merger between the two forms of the disease.
Mapping accuracy
The production of large scale, focus-level maps such as
the one in Figure 5 is made possible by the accuracy of
the geo-referencing procedures adopted for the Atlas.
Results of the spatial accuracy assessment are summar-
ized in Table 4, which provides the number of villages
by country and by category of accuracy.
If the 23 study countries are considered as a whole, the
proportion of villages belonging to the 4 categories of accu-
racy is 59.2 percent for “very high”, 16.5 percent for “high”,
17.1 percent for “medium” and 7.1 percent for “low”. The
resulting average accuracy, based on the estimated average
error of the 4 categories, is approximately 900 m.
It must be noted that the global accuracy of the Atlas
is also potentially affected by homonymies, which can
cause a case of HAT to be associated to the wrong vil-
lage for the only reason of this having the same name as
the correct one. It is impossible to estimate how often
this may have occurred; however, thorough verifications
are carried out to limit this kind of error to a minimum.
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Page 11 of 18The Atlas of HAT as an epidemiological tool for planning,
monitoring and evaluation of disease control
Maps of disease distribution are the first, more visible
output of the HAT Atlas initiative. However, when the
HAT geo-database is coupled with GIS software, it
enables a range of epidemiological analyses to be per-
formed, which are of great value for planning, monitor-
ing and evaluating HAT control programmes. A few
examples of the possible outputs of the Atlas for epide-
miological analysis are given below.
Figure 5 Cases of human African trypanosomiasis (T. b. rhodesiense) reported from the Nkhotakota focus in Malawi (period 2000-
2009). Autochthonous cases are mapped in their places of residence. One exported case is mapped in the centroid of the polygon
representing the park’s boundaries.
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Page 12 of 18Figure 6A allows to monitor whether mobile teams
correctly plan active case finding surveys.
The map shows that a sizable number of cases are
reported by passive surveillance from an area north of
Bodo (Chad) where no active screening was undertaken
in the last five years. This indicates that, when planning
for the next surveys, mobile teams should broaden the
geographical scope of their activities to include this area
of transmission.
Figure 6B allows to evaluate the NSSCP capacity for
early case detection, which has vast implications for
treatment outcome, people’s welfare and long-term dis-
ease control. The ratio (S2 -S 1)/(S1 +S 2) is used, where
S1 and S2 are the numbers of HAT cases in first and
second stage respectively. We note that, predictably,
cases reported from non-surveyed villages tend to dis-
play high rates of second stage infections ((S2 -S 1)/(S1 +
S2) > 0.50). It must be noted that there are gaps in the
field ‘disease stage’ of the HAT DB, as stage is not
always recorded and included in the reports. This
explains why for a few of the lilac circles in (A) there
are no corresponding circles in (B). In this respect,
more recent data (i.e. 2005-2009) are comparatively
more complete than older data (i.e. 2000-2004), due to
improved recording and reporting.
Another example of the Atlas as a tool for monitoring
and evaluation of control activities is in Figure 7, which
shows a time series of maps for the focus of Mbini
(Equatorial Guinea).
Despite active case-finding surveys and subsequent
treatment of detected cases, the focus of Mbini presents
a fairly stable epidemiological pattern and the number
of new infections does not show signs of abatement.
T h es t r a t e g yf o rH A Tc o n t r o li nt h ea r e as h o u l dt h e r e -
fore be reinvigorated. Thanks to the HAT DB, another
factor could be added to this analysis by estimating the
ratio of ‘number of people screened’ to ‘census’,w h i c h
would clarify whether poor performance in reducing the
number of new HAT cases can be ascribed to insuffi-
cient coverage of active screenings, and therefore if sen-
sitization activities should be contemplated.
Discussion
The dramatic development of geospatial technologies
has revolutionized disease mapping by providing tools of
unprecedented accuracy, coverage and affordability
[43-45]. However, several other factors, many of which
are disease-specific, impinge on the mapping of
neglected tropical diseases. Epidemiology, ecology, diag-
nosis, treatment, as well as political and financial com-
mitment, all contribute to shaping how global disease
maps are or can be generated. If treatment is looked at,
we notice that the existence of safe and affordable drugs
against schistosomiasis and soil-transmitted hel-
minthiases enables mass drug administration schemes to
be implemented, thus making detection and mapping of
individual cases unnecessary in many instances [46]; this
fact, combined with the high prevalence of these infec-
tions, has led to mapping approaches based on reviews
of community-based surveys, whose results can be
extrapolated or interpolated to provide regional or glo-
bal coverage [47-49]. Disease ecology is also central to
mapping, in that it can help define bioclimatic and bio-
geographic envelopes within which a pathogen or its
vector can occur. This is aptly demonstrated by rapid
epidemiological mapping methods, first developed for
targeting interventions against onchocerciasis [50,51],
and now also proposed for soil-transmitted hel-
minthiases [46], schistosomiasis [52], and loiasis [53].
Diagnostic methods, and their sensitivity, specificity and
cost, can also have a major impact on disease mapping,
as proved by the repercussions that a new diagnostic
tool [54] had on global mapping of lymphatic filariasis
Table 4 Geographical accuracy of mapped villages
Country Category of accuracy for
mapped villages (number of
villages)
Average
accuracy (m)
Very
high
High Moderate Low
Benin 99 71 21 3 600
Burkina Faso 27 1 0 4 700
Cameroon 76 19 16 0 500
Central African
Republic
251 65 32 49 900
Chad 101 43 49 13 1,000
Congo 476 253 65 80 800
Côte d’Ivoire 145 60 19 5 500
Equatorial Guinea 70 18 22 1 700
Gabon 79 84 52 22 1,200
Ghana 65 31 0 0 200
Guinea 243 19 1 3 100
Kenya 25 2 0 0 100
Malawi 7 7 69 23 2,700
Mali 107 99 1 0 300
Mozambique 0 0 0 2 5,000
Nigeria 14 2 3 4 1,300
Rwanda 0 0 0 0 -
Sudan 148 30 345 88 2,200
Togo 79 9 2 0 100
Uganda 1,216 86 233 85 700
United Republic of
Tanzania
32 1 2 5 800
Zambia 5 10 10 4 1,700
Zimbabwe 1 1 1 2 2,600
Total 3,266 911 943 393 900
Number of mapped villages falling within each of the four categories of
geographical accuracy (by country) and average mapping accuracy (in
metres).
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Page 13 of 18[55,56] From an institutional standpoint, coordination at
the international level is fundamental to develop proto-
cols for systematic and comparable mapping, as demon-
strated by such initiatives as the global Dracunculiasis
Eradication Program [57],t h eG l o b a lP r o g r a m m et o
eliminate lymphatic filariasis [58], the Onchocerciasis
Control Programme in West Africa and the African Pro-
gramme for Onchocerciasis Control [51].
All these factors also shape sleeping sickness mapping.
The severity of HAT outcomes and the toxicity of avail-
able drugs require case-by-case diagnosis [59]. A complex
interplay of ecological factors, not yet fully understood,
Figure 6 HAT focus of Bodo in Chad (period 2005-2009). A: Villages where HAT cases were detected through passive surveillance (lilac
circles) and villages where active case-finding activities were carried out (black dots). B: Disease stage ratio (S1: first stage, S2: second stage)
Figure 7 HAT focus of Mbini in Equatorial Guinea (period 2000-2009). Villages reporting HAT cases (red circles) and villages where active
case-finding surveys were carried out (black dots).
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Notwithstanding variations in transmission intensity, the
geographic distribution of sleeping sickness foci in Africa
has proved fairly stable over time, especially for the Gam-
biense form, thus helping to target costly mass-screening
activities to the known areas of endemicity. On the other
hand, at a more local level, HAT also exhibits complex
spatial and temporal dynamics, with abatements and
resurgences [60,61], contractions, local eliminations [62],
shifts and spreads [63], which call for a detailed represen-
tation in space and time. Another feature of sleeping sick-
ness epidemiology that has relevance for mapping is the
occurrence of disease-free villages lying alongside endemic
ones. Heterogeneities at this fine scale make village-level
mapping a necessity, both for disease control and manage-
ment [10] and also in those contexts where the goal is
local disease elimination [62]. The level of detail of this
Atlas exceeds that of MDA programmes and is compar-
able with the level reached by the eradication programmes.
The importance of an adequate framework for coordi-
nation and collaboration among stakeholders can not be
overstated. Several resolutions of the World Health
Assembly calling to reinforce links with FAO and
increase awareness in the international community
[20,21] spurred WHO to bring together national health
authorities in the affected countries and international
partners (FAO/PAAT, NGOs, Research Institutes), thus
making HAT global mapping possible. One of the many
fields in which coordination contributes to global map-
ping is the WHO-promoted harmonization of survey
and annual reports, which streamlined the flow of infor-
mation and simplified data analysis.
When utilizing the outputs of the HAT Atlas initiative
it is essential to consider that sleeping sickness is a dis-
ease of complex diagnosis and management, which
occurs in remote rural areas where health facilities are
weak or even absent. The risk of under-detection and
underreporting is ever-present, due to possible lapses of
the health information systems and difficulties in acces-
sing some transmission areas because of remoteness or
insecurity [64]. HAT can also be misdiagnosed with
more common diseases presenting similar clinical signs
and symptoms. The combined effect of these factors can
confound the real status of the disease, and the risk of
this happening was extremely high during the 1990s.
However, this risk has since been reduced as a result of
two major developments: (i) discontinuation of social
upheavals and civil strife in most affected countries,
which facilitated access to endemic areas; and (ii) inten-
sified efforts by NGOs, bilateral cooperation and in par-
ticular by WHO that, thanks to a successful Public-
Private Partnership, increased its support to affected
countries, thus leading to strengthened HAT control
and reporting. Keeping these efforts up will be crucial to
sustain and scale up the achieved results.
Despite substantial progress in the accuracy and com-
pleteness of HAT reporting and mapping, a relatively
small proportion of HAT reported cases (fewer that
10%) still can not be located at the village-level. Unra-
velling of these situations relies on progressive acquisi-
tion of more detailed information. The burdensome
process of progressively filling the various gaps will con-
tinue, ultimately aiming at mapping all reported cases at
the village level. Searches for data will only be discontin-
ued if and where insurmountable hurdles to further
improvement should arise. Importantly, all of the
unmapped cases originate from known foci, so that their
absence from the maps has a limited impact on the deli-
neation of HAT transmission areas.
From the methodological standpoint, it must be
stressed that no specific structure or large-scale data
collection activity specifically aimed at global mapping
was put in place for the Atlas of HAT. The Atlas ulti-
mately relies on the reinforced network of NSSCPs,
NGOs, Research Institutions and on the optimal use of
HAT data available at WHO, coupled with the appropri-
ate use of public-domain geographical databases.
Conclusions
The maps presented in this paper represent the state of
knowledge of HAT geographic distribution in 23 out of
25 HAT-endemic countries that reported on sleeping
sickness occurrence during the past ten years (period
2000-2009). These maps are the result of the coordinat-
ing and leadership role of WHO, the partnership with
FAO/PAAT, and of the thorough analysis of unpub-
lished epidemiological reports provided by all stake-
holders involved in HAT control. These maps constitute
a remarkable improvement on previous information
available on this topic (e.g. [22]). The average mapping
error (approximately 900 m), and the overall complete-
ness (i.e. 90.3 percent of all reported cases were
mapped) make the outputs suitable for a range of tech-
nical and scientific applications.
The Atlas of HAT provides more than maps. Minis-
tries of Health, NGOs and Research Institutions can use
the Atlas, and the HAT data repository that underpins
it, to monitor the impact of control activities, assess epi-
demiological trends and plan control or research activ-
ities. Also, it will be possible to combine HAT maps
with the increasing amount of geospatial datasets,
including human and livestock population layers, tsetse
distribution map, land cover datasets, etc. [65], with a
view to improving risk assessment and generating evi-
dence-based estimates of population at risk and disease
burden. The HAT data repository will also help NSSCPs
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Page 15 of 18prevent data losses, which have been a frequent occur-
rence in the history of sleeping sickness, mainly due to
the challenging circumstances in which HAT control is
carried out.
Although initially designated to cover the period 2000
- 2009, the Atlas is a dynamic tool that will be regularly
updated as new information becomes available. The pre-
sent focus is on the completion of the continental map,
by completing mapping in Angola and DRC. At the
same time, the whole database will be refined by pro-
gressively including more precise geographic coordinates
and attempting to map the remaining missing villages.
Finally, HAT-silent countries (i.e. Burundi, Ethiopia,
Gambia, Guinea-Bissau, Liberia, Niger, Senegal and
Sierra Leone) will undertake HAT assessments to clarify
their epidemiological status.
In order to maximize the impact and ensure sustain-
ability of the HAT Atlas initiative, capacity at the country
level will be strengthened through training and provision
of equipment, so that optimal usage of the Atlas can be
made by NSSCPs, and future yearly updating can be envi-
saged at the country-level. Capacity building will also aim
at reinforcing the sense of ownership of this tool in
HAT-affected countries. A range of dissemination media
and outreach activities are anticipated, including an Atlas
proper that will provide disease maps at different scales,
as well as indexed and georeferenced endemic locations.
At the end of the process, the Atlas will be made avail-
able in the public domain free-of-charge through WHO
and FAO/PAAT websites.
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